Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial.

Author: FioravantiPino, Kanony-TrucClaire, PiselliLeonardo, ZaimMohammed

Paper Details 
Original Abstract of the Article :
Iron deficiency anaemia (IDA) is the last stage of iron deficiency, consecutive to an imbalance between iron supply through food intake and iron loss through physiological or pathological processes. As well as by haemoglobin levels, IDA is diagnosed by measuring biomarkers of iron stores. Women are ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00394-011-0210-7

データ提供:米国国立医学図書館(NLM)

Iron Deficiency Anemia: A Common Yet Treatable Condition

Iron deficiency anemia (IDA) is a common condition, especially among women, as they lose iron through menstruation. IDA occurs when there's an imbalance between the iron intake from food and the iron lost through physiological or pathological processes. This imbalance can lead to a shortage of iron stores in the body. This research delves into the effectiveness and tolerance of a prolonged-release ferrous sulfate formulation in treating IDA. The study uses a non-inferiority controlled trial design to assess this new formulation. The researchers aim to find an effective and well-tolerated iron supplement that minimizes gastrointestinal side effects, which often lead to patients discontinuing treatment.

A New Hope for Iron Deficiency Anemia: Prolonged Release Ferrous Sulfate

The results of this study indicate that prolonged-release ferrous sulfate is a promising option for treating IDA. The study demonstrates that this formulation is effective in raising hemoglobin levels and improving iron stores. The authors also emphasize that this formulation is well tolerated, with fewer gastrointestinal side effects than traditional ferrous sulfate preparations. This is crucial, as it can improve patient compliance and increase the chances of successful treatment.

A Better Iron Supplement for Better Health

Iron deficiency anemia can lead to fatigue, shortness of breath, and pale skin. A well-tolerated iron supplement like this prolonged-release formulation can improve these symptoms. However, as Dr. Camel, I encourage everyone to talk to their doctor about iron deficiency and explore the best treatment options. While this prolonged-release ferrous sulfate looks promising, the right treatment plan depends on the individual's unique needs and health status. Eating a balanced diet rich in iron-rich foods, like red meat, spinach, and beans, is also crucial for maintaining healthy iron levels.

Dr.Camel's Conclusion

This research provides valuable insights into the potential of prolonged-release ferrous sulfate in treating IDA. The study's findings are encouraging, suggesting a new, effective, and well-tolerated option for managing this common condition. The implications are significant for improving patient well-being and promoting healthy iron levels.

Date :
  1. Date Completed 2012-06-18
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21643774

DOI: Digital Object Identifier

10.1007/s00394-011-0210-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.